Trial intelligence / Profile preview

Bioequivalence of Clocortolone Pivalate Cream vs Cloderm

NCT04358770Phase 1Completed

Start
Mar 2018
Primary completion
Apr 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 1, randomised, open-label trial of clocortolone pivalate in dermatoses (2 arms). Primary endpoint: Area Under the Effect Curve from 0 to 24 hours. Started Mar 2018; status: completed.

02

Drugs

clocortolone pivalate
03

Conditions

dermatoses

Beyond the preview

Go deeper on NCT04358770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04358770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call